Loading
Latest filing published 02 Sept 2010 for GT Biopharma, Inc., €6,095.
No signal scores available.
Gary M. Post is a declared insider at 2 companies; the most frequent names are GT Biopharma, Inc. and Voip Inc. We count 17 filings; the first trade dates from 2 April 2007 and the latest from 31 August 2010.
No open-market purchase appears, only 10 sales worth €50k. The rest of the record consists of 5 share grants. 2010 to date brings no purchases and 10 sales.
The newest entry dates from 2 September 2010: an open-market sale of €6,095, in GT Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations